.Alnylam is actually putting on hold even further advancement of a clinical-stage RNAi restorative d...
.Takeda has ceased (PDF) a phase 2 trial of danavorexton due to slow enrollment, noting one more var...
.Compass Pathways' trip to stage 3 experimental clinical depression data is taking much longer than ...
.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer last year f...
.On the heels of a period 3 succeed that stopped working to wow capitalists, Ironwood Pharmaceutical...
.Don't cease Monte Rosa Therapies right now. The Boston-based biotech is actually enjoying after sig...
.Welcome to today's Chutes & Ladders, our roundup of notable leadership hirings, firings and also...
.Commemorating his business's upsized initial public offering (IPO), Septerna chief executive office...
.AbbVie has come back to the resource of its antipsychotic goliath Vraylar looking for an additional...
.GenSight Biologics is full weeks away from lacking money. Again. The biotech merely possesses enoug...